90 related articles for article (PubMed ID: 8167441)
1. Effect of oral therapy with monoisoamyl meso-2,3-dimercaptosuccinate on 203Hg retention in rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Bull Environ Contam Toxicol; 1994 Apr; 52(4):492-7. PubMed ID: 8167441
[No Abstract] [Full Text] [Related]
2. Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Kostial K; Kargacin B; Blanusa M; Piasek M; Jones MM; Singh PK
Environ Health Perspect; 1994 Sep; 102 Suppl 3(Suppl 3):309-11. PubMed ID: 7843123
[TBL] [Abstract][Full Text] [Related]
3. Superiority of Mi-ADMS to DMSA as parenteral treatment for decreasing mercury (203Hg) body burden in rats.
Kostial K; Blanusa M; Piasek M; Simonović I; Jones MM; Singh PK
Arh Hig Rada Toksikol; 1993 Sep; 44(3):217-22. PubMed ID: 8311694
[TBL] [Abstract][Full Text] [Related]
4. Monoisoamyl and mono-n-hexyl meso-2,3-dimercaptosuccinate in mobilizing 203Hg retention in relation to age of rats and route of administration.
Kostial K; Blanusa M; Piasek M; Prester L; Jones MM; Singh PK
J Appl Toxicol; 1995; 15(3):201-6. PubMed ID: 7560740
[TBL] [Abstract][Full Text] [Related]
5. Prolonged oral treatment with two monoesters of meso-2,3-dimercaptosuccinic acid for depleting inorganic mercury retention in suckling rats.
Kostial K; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1995 Sep; 77(3):216-8. PubMed ID: 8884886
[TBL] [Abstract][Full Text] [Related]
6. Combined oral treatment with racemic and meso-2,3-dimercaptosuccinic acid for removal of mercury in rats.
Kostial K; Restek-Samarzija N; Blanusa M; Piasek M; Jones MM; Singh PK
Pharmacol Toxicol; 1997 Nov; 81(5):242-4. PubMed ID: 9396091
[TBL] [Abstract][Full Text] [Related]
7. Decreasing 203Hg retention by intraperitoneal treatment with monoalkyl esters of meso-2,3-dimercaptosuccinic acid in rats.
Kostial K; Blanusa M; Simonović I; Jones MM; Singh PK
J Appl Toxicol; 1993; 13(5):321-5. PubMed ID: 8258628
[TBL] [Abstract][Full Text] [Related]
8. Dose-related efficiency of mono-n-hexyl meso-2,3-dimercaptosuccinate in decreasing 203Hg retention in rats.
Kostial K; Blanusa M; Prester L; Jones MM; Singh PK
Pharmacol Toxicol; 1995 Jul; 77(1):79-80. PubMed ID: 8532616
[No Abstract] [Full Text] [Related]
9. Assessment of the protective activity of monisoamyl meso-2,3-dimercaptosuccinate against methylmercury-induced maternal and embryo/fetal toxicity in mice.
Bellés M; Sánchez DJ; Gómez M; Domingo JL; Jones MM; Singh PK
Toxicology; 1996 Jan; 106(1-3):93-7. PubMed ID: 8571406
[TBL] [Abstract][Full Text] [Related]
10. Design of in vivo cadmium-mobilizing agents: synthesis and properties of monobenzyl meso-2,3-dimercaptosuccinate.
Jones MM; Singh PK; Basinger MA; Gale GR; Smith AB; Harris WR
Chem Res Toxicol; 1994; 7(3):367-73. PubMed ID: 8075368
[TBL] [Abstract][Full Text] [Related]
11. Application of sodium dimercaptosuccinate for decrease of radiation burden of renal scintigraphy by chlormerodrin-203Hg.
Vanlić-Razumenić NM; Paunković ND; Drasković RJ; Konstantinovska DD; Maksin TJ
Int J Appl Radiat Isot; 1979 Aug; 30(8):473-80. PubMed ID: 225279
[No Abstract] [Full Text] [Related]
12. Haematological, hepatic and renal alterations after repeated oral or intraperitoneal administration of monoisoamyl DMSA. I. Changes in male rats.
Mehta A; Kannan GM; Dube SN; Pant BP; Pant SC; Flora SJ
J Appl Toxicol; 2002; 22(6):359-69. PubMed ID: 12424740
[TBL] [Abstract][Full Text] [Related]
13. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats.
Bhadauria S; Flora SJ
Cell Biol Toxicol; 2007 Mar; 23(2):91-104. PubMed ID: 17086449
[TBL] [Abstract][Full Text] [Related]
14. [Effect of dimercaptosuccinic acid per os on distribution and excretion of 210Pb and 203Hg in mice].
Liang YY; Zhang JS; Tao ZQ; Yan XM; Xu XH; Chen ZJ
Zhongguo Yao Li Xue Bao; 1994 Jul; 15(4):379-82. PubMed ID: 7801787
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the efficiency of chelation therapy.
Kostial K; Kargacin B; Arezina R; Landeka M; Simonović I
J Hyg Epidemiol Microbiol Immunol; 1991; 35(4):337-50. PubMed ID: 1804865
[TBL] [Abstract][Full Text] [Related]
16. Chelation therapy in intoxications with mercury, lead and copper.
Cao Y; Skaug MA; Andersen O; Aaseth J
J Trace Elem Med Biol; 2015; 31():188-92. PubMed ID: 24894443
[TBL] [Abstract][Full Text] [Related]
17. Monoisoamyl 2, 3-dimercaptosuccinic acid (MiADMSA) demonstrates higher efficacy by oral route in reversing arsenic toxicity: a pharmacokinetic approach.
Flora SJ; Bhadauria S; Pachauri V; Yadav A
Basic Clin Pharmacol Toxicol; 2012 May; 110(5):449-59. PubMed ID: 22117535
[TBL] [Abstract][Full Text] [Related]
18. Effect of monoisoamyl meso-2,3-dimercaptosuccinate on the pathology of acute cadmium intoxication.
Xu C; Holscher MA; Jones MM; Singh PK
J Toxicol Environ Health; 1995 Jul; 45(3):261-77. PubMed ID: 7609002
[TBL] [Abstract][Full Text] [Related]
19. Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats.
Saxena G; Flora SJ
J Pharm Pharmacol; 2006 Apr; 58(4):547-59. PubMed ID: 16597373
[TBL] [Abstract][Full Text] [Related]
20. Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys.
Cremin JD; Luck ML; Laughlin NK; Smith DR
Environ Health Perspect; 2001 Jun; 109(6):613-9. PubMed ID: 11445516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
